Detalhe da pesquisa
1.
Relating influenza virus membrane fusion kinetics to stoichiometry of neutralizing antibodies at the single-particle level.
Proc Natl Acad Sci U S A
; 111(48): E5143-8, 2014 Dec 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-25404330
2.
A common solution to group 2 influenza virus neutralization.
Proc Natl Acad Sci U S A
; 111(1): 445-50, 2014 Jan 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-24335589
3.
Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses.
NPJ Vaccines
; 5: 91, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33083026
4.
A small-molecule fusion inhibitor of influenza virus is orally active in mice.
Science
; 363(6431)2019 03 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30846569
5.
Universal protection against influenza infection by a multidomain antibody to influenza hemagglutinin.
Science
; 362(6414): 598-602, 2018 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30385580
6.
Potent peptidic fusion inhibitors of influenza virus.
Science
; 358(6362): 496-502, 2017 10 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-28971971
7.
HA Antibody-Mediated FcγRIIIa Activity Is Both Dependent on FcR Engagement and Interactions between HA and Sialic Acids.
Front Immunol
; 7: 399, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27746785
8.
The tumor-selective viral protein apoptin effectively kills human biliary tract cancer cells.
J Mol Med (Berl)
; 82(1): 56-63, 2004 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-14647920
9.
Adenovirus types 5 and 35 seroprevalence in AIDS risk groups supports type 35 as a vaccine vector.
AIDS
; 18(8): 1213-6, 2004 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-15166541
10.
A single short stretch of homology between adenoviral vector and packaging cell line can give rise to cytopathic effect-inducing, helper-dependent E1-positive particles.
Hum Gene Ther
; 13(8): 909-20, 2002 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-12031124
11.
Mechanisms of hemagglutinin targeted influenza virus neutralization.
PLoS One
; 8(12): e80034, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24348996
12.
Highly conserved protective epitopes on influenza B viruses.
Science
; 337(6100): 1343-8, 2012 Sep 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-22878502
13.
A highly conserved neutralizing epitope on group 2 influenza A viruses.
Science
; 333(6044): 843-50, 2011 Aug 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-21737702
14.
High-level expression from two independent expression cassettes in replication-incompetent adenovirus type 35 vector.
J Gen Virol
; 88(Pt 11): 2915-2924, 2007 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17947512
15.
Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D.
J Virol
; 81(9): 4654-63, 2007 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-17329340
16.
Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon.
Infect Immun
; 75(8): 4105-15, 2007 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-17526747
17.
Generation of a novel replication-incompetent adenoviral vector derived from human adenovirus type 49: manufacture on PER.C6 cells, tropism and immunogenicity.
J Gen Virol
; 87(Pt 10): 2891-2899, 2006 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-16963747
18.
Age dependence of adenovirus-specific neutralizing antibody titers in individuals from sub-Saharan Africa.
J Clin Microbiol
; 44(10): 3781-3, 2006 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17021110
19.
Immunogenicity of heterologous prime-boost regimens involving recombinant adenovirus serotype 11 (Ad11) and Ad35 vaccine vectors in the presence of anti-ad5 immunity.
J Virol
; 79(15): 9694-701, 2005 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16014931
20.
Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein.
J Immunol
; 174(11): 7179-85, 2005 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15905562